Back to Journals » OncoTargets and Therapy » Volume 11

Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
8,583 Dovepress* 8,027+ 801 8,828
PubMed Central* 556 242 798
Totals 8,583 1,043 9,626
*Since 19 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed and Google Scholar